22 filings
8-K
Coeptis Therapeutics Inc.
28 Oct 22
Submission of Matters to a Vote of Security Holders
9:13am
8-K
Coeptis Therapeutics Inc.
21 Sep 22
Regulation FD Disclosure
12:17pm
8-K
Coeptis Therapeutics Inc.
7 Sep 22
Entry into a Material Definitive Agreement
4:50pm
8-K
Coeptis Therapeutics Inc.
22 Aug 22
Termination of a Material Definitive Agreement
5:24pm
8-K
Coeptis Therapeutics Inc.
6 Jul 22
Regulation FD Disclosure
4:32pm
8-K
f6i4n5df9g1du5jp e96
17 May 22
Option agreement comprises three technologies and associated patent portfolios
5:01pm
8-K
tobt hnyzxl9arrnpu
19 Apr 22
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
4:51pm
8-K
msvn6sv3 zzu
12 Apr 22
Entry into a Material Definitive Agreement
5:21pm
8-K
nubo4 20dbd5
5 Apr 22
Departure of Directors or Certain Officers
5:16pm
8-K
dxa01hhcpyfq vdliv8u
25 Feb 22
Entry into a Material Definitive Agreement
10:53am
8-K
zergh935
27 Dec 21
Entry into a Material Definitive Agreement
4:00pm
8-K
g1zi4xko5zqatqw8c
1 Oct 21
Termination of a Material Definitive Agreement
12:00am
8-K
iv6wn jj2nrbhtyz5hd
27 Aug 21
Termination of a Material Definitive Agreement
12:00am
8-K
8m2drmb5
19 Aug 21
Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets
12:53pm
8-K
7or7z 5rw0m
13 Jul 21
New Corporate Name and Updated Stock Ticker Symbol Highlight Company’s Brand Transformation
2:36pm
8-K
9oi52e annby3db3
11 May 21
Entry into a Material Definitive Agreement
2:20pm
8-K/A
aonf1r
10 May 21
Completion of Acquisition or Disposition of Assets
7:47am
8-K
mio jqjuyhlj
30 Apr 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:19pm
8-K
8h0kngmwezsapzsy3z3s
12 Feb 21
Entry into a Material Definitive Agreement
12:51pm
8-K
xwkttth8i3gn2
4 Jan 21
Entry into a Material Definitive Agreement
3:03pm